The global implantable infusion pumps market size is expected to grow from $17.42 billion in 2021 to $18.26 billion in 2022 at a compound annual growth rate (CAGR) of 4.8%. The global implantable infusion pump market is expected to grow to $21.79 billion in 2026 at a CAGR of 4.5%.
What is the Global Implantable Infusion Pumps Market?
The implantable infusion pumps market consists of sales of implantable infusion pumps and related services by entities (organizations, sole traders, and partnerships) that manufacture implantable infusion pumps. An implantable infusion pump is a small device that is put beneath the skin during the operation. The pump delivers the liquid pain medication to a different part of the body through a long, flexible tube called the catheter.
Get a Sample of the global implantable infusion pumps market report
https://www.thebusinessresearchcompany.com/sample.aspx?id=3347&type=smp
What drives the Global Implantable Infusion Pumps Market?
The increased prevalence of people with chronic pain, cancer, and diabetes is expected to drive the demand for implantable infusion pumps, as these pumps are commonly used to deliver pharmaceutical drugs during the treatment of these diseases. Chronic illnesses and disorders are on the rise around the world, as the aging population and shifts in social behavior lead to a gradual increase in these diseases. In diseases such as chronic arachnoiditis, which is a condition where one of the membranes surrounding the spinal cord swells, implantable infusion pumps deliver lower dosages of drugs and tend to provide more efficient pain relief. The prevalence of chronic diseases is expected to increase by 57% by 2020, according to the World Health Organization. Therefore, the rise in the prevalence of chronic diseases is expected to drive the growth of the implantable infusion pumps market.
Get the full global implantable infusion pumps industry report here
https://www.thebusinessresearchcompany.com/report/implantable-infusion-pumps-global-market-report
Global Implantable Infusion Pumps Market Segments
The global implantable infusion pumps market is segmented:
By Type: Patient-Controlled Analgesia (PCA) Pumps, Enteral Pumps, Insulin Pumps, Elastomeric Pumps, Syringe Pumps, Others
By Application: Oncology, Pediatrics/Neonatology, Gastroenterology, Hematology, Diabetes, Others
By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics
By Geography: The regions covered in the implantable infusion pumps market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Implantable Infusion Pumps Global Market Report 2022provides market size and growth forecasts for the global implantable infusion pumps market, global implantable infusion pumps market share, implantable infusion pumps market segments and geographies, implantable infusion pumps market competitive landscape including leading competitors’ revenues, profiles and market shares. The implantable infusion pumps market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Global Implantable Infusion Pumps Industry Playersinclude Medtronic, Boston Scientific Corporation, Nevro Corporation, Cyberonics, Baxter, B. Braun Melsungen AG, Fresenius Kabi AG, Smiths Medical, Terumo Corporation, and Neuropace. Based on industry trends and company analysis, the report explains a number of strategies for companies in the market.
